PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018
The main objective of this partner is to strengthen national lab systems necessary to conduct quality assured surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB), and to expand access to diagnostic and bio-clinical monitoring services. Quality bio-clinical monitoring and training is key to USG commitments related to the PF goal of scaling up and enhancing antiretroviral treatment services (including pre-ART) [and] reducing TB/HIV co-infection. Technical assistance aids the GRN to enhance the quality of ART care through quality assured bio-clinical monitoring, and expand access to screening for TB/HIV co-infection and other opportunistic infections. The NIPs laboratory network coverage is national. The Namibia Institute of Pathology (NIP) is a public company established in 1999. Since then it has assumed responsibility for 37 MOHSS labs. This approach has allowed for a single lab structure within the HIV/AIDS response. NIP recovers a substantial portion of its costs through reimbursements from insurance plans. This innovative cost-recovery system is a model that could be adapted by other GRN programs. All cooperative agreement grantees must submit a detailed work plan with their annual continuation application. This work plan must be based on PEPFAR indicators and aligned with targets set for each country. NIP also submits bi-annual status reports to CDC; these reports are shared with CDC technical advisors and the financial manager. Regular meetings between the CDC coag management team and the grantee allow for monitoring, advance planning and the identification of any redirection needs during the course of a budget period.
Global Fund / Programmatic Engagement Questions
1. Is the Prime Partner of this mechanism also a Global Fund principal or sub-recipient, and/or does this mechanism support Global Fund grant implementation? No
Salary Support for NIP TB staff will be provided in COP12. The following NIP positions will be supported:One medical technologist for Quality Assurance (QA): The TB QA technologist is responsible for monitoring the implementation of quality assurance indicators at all NIP TB microscopy and culture labs, managing proficiency testing results, doing blind slides, rechecking, and site supervisions.Six laboratory assistants: The Laboratory assistants are deployed as microscopists and lab aids at district level laboratories. These are good examples of task shifting in the context of lack of qualified lab technologists.
Procurement and maintenance of equipment: NIP will continue to strengthen its peripheral laboratories by procuring and maintaining equipment to make diagnostics and basic bio-clinical monitoring services accessible to remote areas. COP12 funds will also be used to maintain laboratory information system equipment that links remote health facilities to the main laboratory system. Increased access to laboratory services will minimize costs, delays and risk of loss associated with transporting samples to central testing facilities.Salary support. COP12 funds will support the following NIP salaries:-two laboratory trainers;-one administrative assistant assigned to the training unit; and-one program officer based at NIP.
The training positions will support the NIP training unit to leverage external TA in training provided by International partners (ASCP, ASM, CLSI). The training unit will focus on in-service training (internships), and practical training for Polytechnic of Namibia laboratory tech students. The NIP program officer together with the Corporate Affairs Manager is responsible for the management of the NIP COAG. This management team works closely with the CDC technical advisor, the CDC project manager, and the CDC finance department.
Ongoing Quality Assurance (QA) for Rapid Testing (RT): These activities support the expansion of HCT through traditional and non-traditional delivery models, such as provider-initiated testing and counseling (PITC), outreach testing (e.g., mobile and door-to-door) as well as existing HCT. The MOHSS requires retesting of 5% of all rapid HIV testing done as part of external quality monitoring. All HCT facilities are enrolled in the EQA scheme and are expected to submit the 5% specimens for retesting using ELISA at NIP. Additionally, NIP provides proficiency panels and Quality Control sets to all rapid test sites and compiles EQA reports for the program.
Salary Support for Staff: QA staff will be responsible for the validation of any new RT technologies introduced in Namibia, and for making recommendations to the MOHSS on the RT algorithm and selection of test kits. These QA experts will also support training and post-training certification of all MOHSS/New Start/NGO personnel who administer rapid tests, preparation, distribution, and analysis of quality controls and proficiency panels; retesting of 5% of all rapid tests done at sites by ELISA; proficiency follow-up with rapid test sites and personnel; and; submission of reports on rapid test QA to the MOHSS HCT unit.Support for QA staff within NIP is designed to support the national HCT strategy to diagnose and refer a greater number of newly infected patients into ART services and treatment.CDC will continue to work with NIP and the USG-GRN HRH TWG to develop and implement rational transition plans for all staff currently supported with PEPFAR funds.
